Two investment firms have acquired large stakes in global CRO Novotech, the Singapore-based company announced March 30. GIC ...
Since TPG’s investment in 2017, the firm has raised its headcount tenfold to 3,000 employees and expanded its operations ...
The two sovereign wealth funds have taken a “significant stake” in the clinical research business owned by the private equity ...
Temasek Holdings Pte and GIC Pte Ltd. will acquire a significant stake in Novotech Pty Ltd. to fuel growth and accelerate ...
Temasek Holdings Pte and GIC Pte Ltd. will acquire a significant stake in Novotech Pty Ltd. to fuel growth and accelerate ...
Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a ...
Explore more
SYDNEY, March 31, 2025--(BUSINESS WIRE)--Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek ...
Novotech, a top global clinical trial provider, partners with biotech and pharma to speed siRNA therapeutic development.
1d
Singapore Business Review on MSNGIC, Temasek to acquire ‘significant stake’ in biotech CRO NovotechNovotech provides biotech to small and mid-sized pharma companies. GIC and Temasek have signed a binding agreement to acquire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results